Showing results (1331-1340 of 1,823) with videos related to

Sort By:
Pageof 183
Transplantation and Cellular Therapy|June 16, 2026
Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall SurvivalGurbakhash Kaur, Jennifer Logue, Ruta Brazauskas, et al.
Transplantation and Cellular Therapy|July 1, 2026
Real-world use of maribavir for refractory CMV infection and intolerance to conventional anti-CMV agents after allogeneic hematopoietic cell transplantationRisa Nishiyama, Ayumu Ito, Yu Akahoshi, et al.
Transplantation and Cellular Therapy|June 18, 2026
Trends and Disparities in CAR-T Therapy Utilization, Inpatient Mortality, Length of Stay, and Costs in the United States (2017-2022)Simo Du, Jiahao Peng, Tiantian Zhang, et al.
Transplantation and Cellular Therapy|July 8, 2026
Beyond Conventional CARs: Expanding the Targetable Antigen Landscape in CAR-T Cell TherapyUmida Yoziyeva, Alexey Yumashev, Shakhodat Kobilova, et al.
Transplantation and Cellular Therapy|June 24, 2026
Outcomes of Tocilizumab for Cytokine Release Syndrome After Post-Transplant CyclophosphamideTuan L Phan, Roberta Azbell, Hannah Choe, et al.
Transplantation and Cellular Therapy|June 23, 2026
Absence of pretransplant peripheral blasts is a favorable factor in allogeneic stem cell transplantation for advanced acute lymphoblastic leukemiaHiroyasu Ogawa, Katsuji Kaida, Takayuki Inoue, et al.
Transplantation and Cellular Therapy|June 26, 2026
International Survey and NGS-Based Indel Chimerism Detection of HLA Loss in Relapsed Haploidentical andMismatched Unrelated Donor Transplant RecipientsNihar Desai, Linnea Pettersson, Jinguo Wang, et al.
Transplantation and Cellular Therapy|June 25, 2026
A Retrospective Study Evaluating the Efficacy of Fludarabine, Cytarabine, and Granulocyte Colony Stimulating Factor with/without Idarubicin Followed by Second Allogenic Stem Cell Transplant in the Treatment of Relapsed/Refractory AML/MDS Following First Allogenic Stem Cell TransplantJacqueline Hsieh-Wong, Brian Pham, Joseph Tuscano, et al.
Transplantation and Cellular Therapy|June 26, 2026
Predictors of Rehabilitation Utilization After CAR T-Cell TherapyHanan Alharthy, Abdulaziz Abu-Haimed, Renu E Thomas, et al.
Transplantation and Cellular Therapy|August 2, 2026
Toward Standardized Screening for Chronic GVHD: Insights from the Engraft Learning NetworkLaila Alkhouli, Seth Rotz, Christopher Dandoy, et al.
Pageof 183